Educational & Guideline Reference Notice: Unranked FDA-label and national guideline option categories and recruiting clinical trials for discussion with a licensed oncologist. Protocol drug dosing and autonomous treatment prescriptions are excluded.
Colorectal Cancer (CRC) — 507 Curated Clinical Trials
| NCT Identifier | Title & Sponsor | Phase / Status |
|---|---|---|
| NCT01174121 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer | PHASE2 RECRUITING |
| NCT01365169 | Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" | NA RECRUITING |
| NCT02000089 | The Cancer of the Pancreas Screening-5 CAPS5)Study | PHASE3 RECRUITING |
| NCT02172651 | Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases | EARLY_PHASE1 RECRUITING |
| NCT02448173 | A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer | PHASE3 NOT_YET_RECRUITING |
| NCT02584244 | Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers | PHASE1|PHASE2 RECRUITING |
| NCT02600949 | Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer | PHASE1 ACTIVE_NOT_RECRUITING |
| NCT03051464 | Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery | PHASE2|PHASE3 RECRUITING |
| NCT03093116 | A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | PHASE1|PHASE2 RECRUITING |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | PHASE2 RECRUITING |
| NCT03190941 | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients | PHASE1|PHASE2 RECRUITING |
| NCT03516708 | Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer | PHASE1|PHASE2 RECRUITING |
| NCT03526835 | A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT03539822 | Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies | PHASE1|PHASE2 RECRUITING |
| NCT03594630 | Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer | EARLY_PHASE1 RECRUITING |
| NCT03659448 | Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer | PHASE3 RECRUITING |
| NCT03692429 | alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells | PHASE1 RECRUITING |
| NCT03715933 | Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | PHASE1 RECRUITING |
| NCT03740256 | Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors | PHASE1 RECRUITING |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | PHASE1 RECRUITING |
| NCT03823144 | Intravital Microscopy in Human Solid Tumors | NA RECRUITING |
| NCT03947385 | Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions | PHASE1|PHASE2 RECRUITING |
| NCT03965234 | Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases | PHASE1|PHASE2 RECRUITING |
| NCT04165772 | Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors | PHASE2 RECRUITING |
| NCT04184973 | Efficacy and Safety of the CG-100 Intraluminal Bypass Device | NA RECRUITING |
| NCT04221893 | Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers | NA RECRUITING |
| NCT04222413 | Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT04282044 | Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies | PHASE1 RECRUITING |
| NCT04329494 | PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer | PHASE1 RECRUITING |
| NCT04339374 | Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer | NA RECRUITING |
| NCT04373564 | Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years | PHASE4 RECRUITING |
| NCT04421820 | BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours | PHASE1|PHASE2 RECRUITING |
| NCT04429542 | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT04494945 | Identifying and Caring for Individuals With Inherited Cancer Syndrome | NA RECRUITING |
| NCT04511039 | Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer | PHASE1 RECRUITING |
| NCT04585750 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | PHASE1|PHASE2 RECRUITING |
| NCT04589468 | Researching the Effect of Exercise on Cancer | NA RECRUITING |
| NCT04643366 | Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer | PHASE2 RECRUITING |
| NCT04657068 | A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT04674267 | Resilience and Equity in Aging, Cancer, and Health (REACH) | NA RECRUITING |
| NCT04678648 | A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies | PHASE1 RECRUITING |
| NCT04693377 | Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial | NA RECRUITING |
| NCT04701476 | TATE and Pembrolizumab (MK3475) in mCRC and NSCLC | PHASE2 RECRUITING |
| NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | PHASE1 RECRUITING |
| NCT04722341 | Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators | NA RECRUITING |
| NCT04751435 | Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients | NA RECRUITING |
| NCT04771520 | Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors | PHASE2 RECRUITING |
| NCT04779554 | Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC | PHASE2 RECRUITING |
| NCT04796818 | An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response | NA RECRUITING |
| NCT04808323 | MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer | PHASE1 RECRUITING |
| NCT04847063 | Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies | PHASE1 RECRUITING |
| NCT04851119 | Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT04895709 | A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT04899908 | Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases | PHASE2 RECRUITING |
| NCT04907643 | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | NA RECRUITING |
| NCT04913285 | A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors | PHASE1 RECRUITING |
| NCT04916990 | Improving Care for Rural Patients With Solid Tumors | NA RECRUITING |
| NCT04920032 | Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas | PHASE1 RECRUITING |
| NCT04929223 | A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) | PHASE1 RECRUITING |
| NCT04991948 | Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer | PHASE1 RECRUITING |
| NCT05005403 | Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan | PHASE1 RECRUITING |
| NCT05024097 | A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer. | PHASE2 RECRUITING |
| NCT05053555 | High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies | NA RECRUITING |
| NCT05062317 | ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases | PHASE2 RECRUITING |
| NCT05064280 | Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases | PHASE2 RECRUITING |
| NCT05080673 | Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps | NA RECRUITING |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study | PHASE1|PHASE2 RECRUITING |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | PHASE1 RECRUITING |
| NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | PHASE2|PHASE3 RECRUITING |
| NCT05174286 | Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk | NA RECRUITING |
| NCT05176483 | Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors | PHASE1 RECRUITING |
| NCT05195710 | Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases | PHASE1 RECRUITING |
| NCT05204147 | Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers | PHASE1 RECRUITING |
| NCT05225428 | Video Education With Result Dependent dIsclosure | NA COMPLETED |
| NCT05239546 | Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers | PHASE2 RECRUITING |
| NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | PHASE3 RECRUITING |
| NCT05254327 | Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001 | PHASE2 RECRUITING |
| NCT05265169 | Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) | NA RECRUITING |
| NCT05283330 | Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors | PHASE1 RECRUITING |
| NCT05286814 | PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma | PHASE2 RECRUITING |
| NCT05296681 | Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery | PHASE2 RECRUITING |
| NCT05297734 | Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer | NA RECRUITING |
| NCT05319314 | LYL273 for Patients With Relapsed or Refractory mCRC | PHASE1|PHASE2 RECRUITING |
| NCT05321134 | Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery | NA RECRUITING |
| NCT05346796 | Survivorship Plan HEalth REcord (SPHERE) Implementation Trial | NA RECRUITING |
| NCT05379595 | A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer | PHASE1|PHASE2 RECRUITING |
| NCT05379985 | Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS | PHASE1|PHASE2 RECRUITING |
| NCT05391126 | GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care | NA RECRUITING |
| NCT05411718 | A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome | PHASE2 RECRUITING |
| NCT05412082 | SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer | PHASE1 RECRUITING |
| NCT05428735 | The DRAGON 2 Trial | NA RECRUITING |
| NCT05433142 | Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma | PHASE1 RECRUITING |
| NCT05447923 | Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities | NA RECRUITING |
| NCT05482516 | Evaluating Novel Therapies in ctDNA Positive GI Cancers | PHASE3 ACTIVE_NOT_RECRUITING |
| NCT05482893 | Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) | PHASE1|PHASE2 RECRUITING |
| NCT05489211 | Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) | PHASE2 RECRUITING |
| NCT05524428 | Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study | NA RECRUITING |
| NCT05556473 | F-Tryptophan PET/CT in Human Cancers | PHASE1 COMPLETED |
| NCT05584670 | A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT05592626 | A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT05612347 | Colonoscopy vs Stool Testing for Older Adults With Colon Polyps | NA RECRUITING |
| NCT05630794 | Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 | PHASE1 RECRUITING |
| NCT05643859 | Impact of Dietary Fiber Supplementation on Colonic Microbiome | NA RECRUITING |
| NCT05649072 | Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. | NA RECRUITING |
| NCT05663203 | A Web-Based Dyadic Intervention for Colorectal Cancer | NA RECRUITING |
| NCT05669430 | A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies | PHASE1|PHASE2 RECRUITING |
| NCT05672108 | Phase II Trial of Lung Chemoemobolization | PHASE2 RECRUITING |
| NCT05672524 | A Study of Tucatinib and Trastuzumab in People With Rectal Cancer | PHASE2 RECRUITING |
| NCT05673148 | Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial | PHASE2 RECRUITING |
| NCT05686226 | E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | PHASE2 RECRUITING |
| NCT05691491 | Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness | PHASE1|PHASE2 RECRUITING |
| NCT05692024 | COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER | PHASE1|PHASE2 RECRUITING |
| NCT05694559 | Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics | NA RECRUITING |
| NCT05705492 | Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer | PHASE2 RECRUITING |
| NCT05719558 | A Study of ASP1002 in Adults for Treatment of Solid Tumors | PHASE1 RECRUITING |
| NCT05733000 | CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors | PHASE2 RECRUITING |
| NCT05742178 | NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation | NA RECRUITING |
| NCT05746897 | A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT05773144 | Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer | NA RECRUITING |
| NCT05780684 | Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer | NA RECRUITING |
| NCT05784688 | Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT05785780 | Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings | NA ENROLLING_BY_INVITATION |
| NCT05786924 | Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies | PHASE1|PHASE2 RECRUITING |
| NCT05789433 | Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer | NA RECRUITING |
| NCT05803382 | Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers | PHASE1 RECRUITING |
| NCT05806931 | Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT05824975 | A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) | PHASE1|PHASE2 RECRUITING |
| NCT05826743 | Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy | NA RECRUITING |
| NCT05854498 | Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | PHASE3 RECRUITING |
| NCT05856981 | Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT05863195 | Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial | PHASE3 RECRUITING |
| NCT05868226 | PRE-ISPY Phase I/II Oncology Platform Program | PHASE1|PHASE2 RECRUITING |
| NCT05870800 | Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER | PHASE2 RECRUITING |
| NCT05877599 | A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation | PHASE1 RECRUITING |
| NCT05914766 | An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer | NA RECRUITING |
| NCT05919264 | FOG-001 in Locally Advanced or Metastatic Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT05936931 | Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening | NA NOT_YET_RECRUITING |
| NCT05943210 | The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer | NA RECRUITING |
| NCT05947838 | A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma | NA RECRUITING |
| NCT05969860 | At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer | PHASE2 RECRUITING |
| NCT05984589 | Personalized Health Self-Management Training for Colorectal Cancer Survivors | NA RECRUITING |
| NCT05985954 | Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy | PHASE1 RECRUITING |
| NCT06004245 | A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06026410 | KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06037954 | A Study of Mental Health Care in People With Cancer | NA RECRUITING |
| NCT06040541 | Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors | PHASE1 RECRUITING |
| NCT06047379 | Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis | PHASE1|PHASE2 RECRUITING |
| NCT06051695 | A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression | PHASE1|PHASE2 RECRUITING |
| NCT06055439 | A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy | PHASE1|PHASE2 ACTIVE_NOT_RECRUITING |
| NCT06063928 | Confronting Cancer as a Community | NA RECRUITING |
| NCT06065371 | Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy | PHASE1 RECRUITING |
| NCT06085560 | Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening | NA ENROLLING_BY_INVITATION |
| NCT06101277 | Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) | NA RECRUITING |
| NCT06102902 | Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer | PHASE1 RECRUITING |
| NCT06117241 | Reducing Metabolic Dysregulation in Dyads | NA RECRUITING |
| NCT06128551 | Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT06130280 | A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer | PHASE2 RECRUITING |
| NCT06130826 | Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer | PHASE1 ACTIVE_NOT_RECRUITING |
| NCT06131840 | A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06133439 | Rural Indiana Screening for Colorectal Cancer | NA ENROLLING_BY_INVITATION |
| NCT06134687 | Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection | NA RECRUITING |
| NCT06149481 | Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) | PHASE1|PHASE2 RECRUITING |
| NCT06159634 | Traction vs. No Traction in Colonic ESD | NA RECRUITING |
| NCT06179160 | A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation | PHASE1 RECRUITING |
| NCT06184594 | Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening | NA ENROLLING_BY_INVITATION |
| NCT06191185 | IMProving Adherence to Colonoscopy Through Teams and Technology | NA ACTIVE_NOT_RECRUITING |
| NCT06202183 | Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial | NA RECRUITING |
| NCT06205485 | Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer | PHASE3 RECRUITING |
| NCT06205836 | Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer | PHASE2 RECRUITING |
| NCT06218914 | Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT06225011 | Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer | PHASE1 RECRUITING |
| NCT06228209 | Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer | NA RECRUITING |
| NCT06239194 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT06242470 | A Study of MGC026 in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06244771 | A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT06252649 | Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation | PHASE3 RECRUITING |
| NCT06253871 | A Phase 1/1b Study of IAM1363 in HER2 Cancers | PHASE1 RECRUITING |
| NCT06258525 | SAMe in Prevention of Oxaliplatin-associated Liver Injury | PHASE2 NOT_YET_RECRUITING |
| NCT06263088 | EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. | NA RECRUITING |
| NCT06265285 | Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program | PHASE2 RECRUITING |
| NCT06269744 | Proactive Outreach With FIT | NA ENROLLING_BY_INVITATION |
| NCT06270706 | A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT06281678 | A Study of IBI363 in Subjects with Advanced Solid Malignancies | PHASE2 RECRUITING |
| NCT06298916 | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer | PHASE1|PHASE2 RECRUITING |
| NCT06300463 | Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases | PHASE2 RECRUITING |
| NCT06307548 | Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer | PHASE1|PHASE2 RECRUITING |
| NCT06324357 | Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread | PHASE1|PHASE2 RECRUITING |
| NCT06330064 | A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) | PHASE1|PHASE2 RECRUITING |
| NCT06336902 | Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer | PHASE1 RECRUITING |
| NCT06340646 | Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) | NA RECRUITING |
| NCT06349590 | Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery | PHASE1|PHASE2 RECRUITING |
| NCT06362369 | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy | PHASE1|PHASE2 RECRUITING |
| NCT06369259 | Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer | PHASE2 RECRUITING |
| NCT06371768 | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors | NA RECRUITING |
| NCT06376565 | Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps | NA RECRUITING |
| NCT06380101 | Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) | NA RECRUITING |
| NCT06384352 | Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06385925 | A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation | PHASE1|PHASE2 RECRUITING |
| NCT06395519 | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies | PHASE1|PHASE2 RECRUITING |
| NCT06400472 | A Study of Sofe-M in Participants With Selected Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06401174 | Patient Navigation for Colorectal Cancer Screening | NA ENROLLING_BY_INVITATION |
| NCT06411691 | KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer | PHASE1 RECRUITING |
| NCT06412198 | A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations | PHASE1|PHASE2 RECRUITING |
| NCT06424522 | A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients | NA RECRUITING |
| NCT06428409 | A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) | PHASE1|PHASE2 RECRUITING |
| NCT06440005 | A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06444815 | A Study of VET3-TGI in Patients With Solid Tumors | PHASE1 RECRUITING |
| NCT06445062 | Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT06451497 | This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06458998 | Getting To Implementation: Improving Cancer Screening for Veterans | NA ENROLLING_BY_INVITATION |
| NCT06462521 | Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection | NA ENROLLING_BY_INVITATION |
| NCT06496256 | Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial | NA RECRUITING |
| NCT06528990 | Telehealth Intervention for Ostomy Self-Management | PHASE2 RECRUITING |
| NCT06529523 | Tislelizumab in People With Colorectal Cancer | PHASE2 RECRUITING |
| NCT06534918 | Precise Oncology Interventions in Nutrition and Training (OnPoint) | NA RECRUITING |
| NCT06542835 | Community Partnership for Telehealth Solutions to Convey Information and Enhance Care | NA COMPLETED |
| NCT06553885 | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC | PHASE2 RECRUITING |
| NCT06555133 | Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC | PHASE2 RECRUITING |
| NCT06555588 | Engage Psychosocial Intervention for Cancer Symptoms | NA RECRUITING |
| NCT06557733 | An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis | PHASE2 RECRUITING |
| NCT06559059 | Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs | NA RECRUITING |
| NCT06562192 | Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers | PHASE1 RECRUITING |
| NCT06562543 | A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer | PHASE4 RECRUITING |
| NCT06563388 | Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial | PHASE3 RECRUITING |
| NCT06565052 | The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial | NA RECRUITING |
| NCT06568016 | A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers | NA RECRUITING |
| NCT06569368 | Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy | PHASE2 RECRUITING |
| NCT06576037 | Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin | PHASE1 RECRUITING |
| NCT06578637 | Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis | NA ENROLLING_BY_INVITATION |
| NCT06580002 | Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial | PHASE2 RECRUITING |
| NCT06586515 | MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors | PHASE1 ACTIVE_NOT_RECRUITING |
| NCT06589440 | Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | PHASE2 RECRUITING |
| NCT06598007 | A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT06603519 | Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy | NA ENROLLING_BY_INVITATION |
| NCT06605430 | Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer | PHASE2 RECRUITING |
| NCT06607458 | Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease | PHASE2 RECRUITING |
| NCT06612281 | Evaluation of Gixam's Performance in a FIT Negative Population | PHASE2 RECRUITING |
| NCT06617858 | Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment | PHASE2 RECRUITING |
| NCT06625775 | Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06634875 | Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) | PHASE2 RECRUITING |
| NCT06637462 | A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer | NA RECRUITING |
| NCT06638502 | Safety of HRX215 in Patients After Minor and Major Liver Resection | PHASE1|PHASE2 RECRUITING |
| NCT06641310 | Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP) | NA RECRUITING |
| NCT06654037 | Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer | PHASE1 RECRUITING |
| NCT06656936 | The PharmFIT Study | NA NOT_YET_RECRUITING |
| NCT06657144 | A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer | PHASE3 RECRUITING |
| NCT06663319 | A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers | PHASE1 RECRUITING |
| NCT06666192 | The Ohio State University (OSU) SCREEN Community Program | NA RECRUITING |
| NCT06669572 | Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment | PHASE2 RECRUITING |
| NCT06673329 | Brodalumab in the Treatment of Immune-Related Adverse Events | PHASE1 RECRUITING |
| NCT06682650 | Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics) | NA RECRUITING |
| NCT06682793 | A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression | PHASE1|PHASE2 RECRUITING |
| NCT06695845 | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors | PHASE2 RECRUITING |
| NCT06696768 | Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer | PHASE1 RECRUITING |
| NCT06710756 | Lead-212 PSV359 Therapy for Patients With Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT06720987 | A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies | PHASE1 RECRUITING |
| NCT06723236 | A Study of MGC028 in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06728072 | Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer | PHASE2 RECRUITING |
| NCT06731894 | Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors | PHASE2 RECRUITING |
| NCT06731998 | Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery | NA RECRUITING |
| NCT06745895 | Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening | NA RECRUITING |
| NCT06746012 | Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers | NA RECRUITING |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy | PHASE3 RECRUITING |
| NCT06751329 | A Study of DM002 in Patients With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT06756035 | CT-95 in Advanced Cancers Associated With Mesothelin Expression | PHASE1 RECRUITING |
| NCT06760819 | A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) | PHASE2 RECRUITING |
| NCT06764771 | A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors | PHASE1 RECRUITING |
| NCT06778863 | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation | PHASE1 RECRUITING |
| NCT06780787 | FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery | PHASE2 RECRUITING |
| NCT06789172 | A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors | PHASE1 RECRUITING |
| NCT06792695 | A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer | PHASE2 ACTIVE_NOT_RECRUITING |
| NCT06802172 | Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial | NA RECRUITING |
| NCT06811454 | Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) | NA NOT_YET_RECRUITING |
| NCT06819228 | Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer | PHASE1 RECRUITING |
| NCT06820463 | A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT06822530 | A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial | NA RECRUITING |
| NCT06824064 | Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer | PHASE2 RECRUITING |
| NCT06833866 | Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer | PHASE1 RECRUITING |
| NCT06834126 | Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial | PHASE1 RECRUITING |
| NCT06835569 | A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations | PHASE1 RECRUITING |
| NCT06843434 | A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma | PHASE2 RECRUITING |
| NCT06885034 | A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201) | PHASE1|PHASE2 RECRUITING |
| NCT06885697 | Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma | PHASE1 RECRUITING |
| NCT06887218 | 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT06887673 | Lipid Mediators & Cancer: Montelukast, SPM, and Almonds | EARLY_PHASE1 NOT_YET_RECRUITING |
| NCT06896162 | PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival | NA RECRUITING |
| NCT06910657 | IDOV-Immune for Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT06914726 | Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes | NA ENROLLING_BY_INVITATION |
| NCT06917079 | BBO-11818 in Adult Subjects With KRAS Mutant Cancer | PHASE1 RECRUITING |
| NCT06931860 | Head to Head Trial of Mailed Cologuard to Mailed FIT | NA ENROLLING_BY_INVITATION |
| NCT06934538 | First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer | PHASE1|PHASE2 RECRUITING |
| NCT06937177 | Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy | PHASE2 RECRUITING |
| NCT06948448 | A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer | PHASE2 RECRUITING |
| NCT06950385 | Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis | PHASE3 RECRUITING |
| NCT06959550 | Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT06973564 | JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration | PHASE1|PHASE2 RECRUITING |
| NCT06974110 | Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT06983743 | A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT06992258 | A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT06995898 | The Vanguard Study: Testing a New Way to Screen for Cancer | NA RECRUITING |
| NCT06995924 | Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education | NA RECRUITING |
| NCT06997497 | A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) | PHASE3 RECRUITING |
| NCT07011576 | A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL) | PHASE2 RECRUITING |
| NCT07018869 | Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors | PHASE3 RECRUITING |
| NCT07020117 | A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors | PHASE1 RECRUITING |
| NCT07020221 | A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07023289 | A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease | PHASE2 RECRUITING |
| NCT07030257 | Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07033026 | An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. | PHASE2 RECRUITING |
| NCT07042243 | The Florida ASCENT Study | NA RECRUITING |
| NCT07042685 | Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT07044362 | Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis | NA RECRUITING |
| NCT07050485 | Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery | NA ENROLLING_BY_INVITATION |
| NCT07058012 | A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE) | PHASE2 RECRUITING |
| NCT07059884 | Distance-Based Exercise to Preserve Function and Prevent Disability | NA RECRUITING |
| NCT07066657 | A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07070232 | A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07071454 | Preventing Early-Onset Colorectal Cancer in the VA | NA NOT_YET_RECRUITING |
| NCT07071961 | Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] | PHASE2 RECRUITING |
| NCT07079631 | A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer | PHASE1|PHASE2 RECRUITING |
| NCT07082439 | Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma | PHASE2 RECRUITING |
| NCT07085091 | A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors | PHASE1 RECRUITING |
| NCT07086833 | The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities | NA RECRUITING |
| NCT07091032 | Building Connections | NA RECRUITING |
| NCT07094113 | AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT07094204 | A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors | PHASE1 RECRUITING |
| NCT07095517 | Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors | PHASE1 RECRUITING |
| NCT07106359 | Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome | NA RECRUITING |
| NCT07114601 | A Study of LY4257496 in Participants With Cancer (OMNIRAY) | PHASE1 RECRUITING |
| NCT07115875 | Improving Rates of Diagnostic Colonoscopy in Native Americans | NA NOT_YET_RECRUITING |
| NCT07116668 | SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study | NA ENROLLING_BY_INVITATION |
| NCT07125729 | Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients | NA RECRUITING |
| NCT07127874 | A Study of PHN-012 in Patients With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07128355 | Botensilimab, Balstilimab, and SBRT in Colorectal Cancer | EARLY_PHASE1 RECRUITING |
| NCT07130903 | Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer | PHASE2 RECRUITING |
| NCT07140679 | Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer | PHASE2 RECRUITING |
| NCT07141901 | Life Expectancy-informed Colorectal Cancer Screening | NA NOT_YET_RECRUITING |
| NCT07143487 | Family Communications After Genetic Testing | NA RECRUITING |
| NCT07145255 | Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07147231 | Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer | PHASE1|PHASE2 RECRUITING |
| NCT07148128 | Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. | PHASE1|PHASE2 RECRUITING |
| NCT07153614 | Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy | NA RECRUITING |
| NCT07158164 | DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment | PHASE4 RECRUITING |
| NCT07161713 | SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors | NA RECRUITING |
| NCT07162337 | BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention | NA RECRUITING |
| NCT07167446 | Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy | EARLY_PHASE1 RECRUITING |
| NCT07169734 | A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07172282 | INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases | EARLY_PHASE1 RECRUITING |
| NCT07173985 | Strategies for Optimizing a Mailed FIT Program in Appalachia | NA RECRUITING |
| NCT07183046 | Implementation Intention Planning Guide for FIT Colon Cancer Screening | NA NOT_YET_RECRUITING |
| NCT07186842 | A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 | PHASE1|PHASE2 RECRUITING |
| NCT07189871 | 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07193862 | Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis | EARLY_PHASE1 RECRUITING |
| NCT07198945 | Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection | NA ENROLLING_BY_INVITATION |
| NCT07201519 | Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy | PHASE2 RECRUITING |
| NCT07209215 | ctDNA-Informed Management of Early-Stage Rectal Cancer | PHASE2 NOT_YET_RECRUITING |
| NCT07213609 | A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07213791 | A Study of LY4337713 in Participants With FAP-Positive Solid Tumors | PHASE1 RECRUITING |
| NCT07215000 | Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial | PHASE4 RECRUITING |
| NCT07216105 | FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07216560 | First-in-human Study of 7MW4911 in GI Cancer | PHASE1|PHASE2 RECRUITING |
| NCT07219238 | Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) | PHASE2|PHASE3 RECRUITING |
| NCT07219537 | A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule | NA RECRUITING |
| NCT07219745 | Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS) | NA NOT_YET_RECRUITING |
| NCT07220018 | Colorectal Cancer Screening in the Homeless | NA RECRUITING |
| NCT07220239 | Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome | NA RECRUITING |
| NCT07221058 | Adaptive Radiation Boost for Rectal Cancer | PHASE1 RECRUITING |
| NCT07221357 | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer | PHASE2|PHASE3 RECRUITING |
| NCT07222800 | Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer | PHASE3 RECRUITING |
| NCT07223047 | A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies | PHASE1|PHASE2 RECRUITING |
| NCT07223424 | Patient Preference for Subcutaneous vs. Intravenous Immune Therapy | PHASE2 RECRUITING |
| NCT07224464 | The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. | NA RECRUITING |
| NCT07225309 | A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer | NA RECRUITING |
| NCT07227077 | Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial | NA RECRUITING |
| NCT07227168 | A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer | PHASE1 RECRUITING |
| NCT07227636 | A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy | PHASE2 RECRUITING |
| NCT07228000 | Bundled Cancer Screening and Genetic Services Navigation | NA RECRUITING |
| NCT07228832 | Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer | PHASE3 RECRUITING |
| NCT07229313 | A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT07230795 | AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake | NA ENROLLING_BY_INVITATION |
| NCT07234968 | Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy | NA RECRUITING |
| NCT07235293 | A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. | PHASE2 RECRUITING |
| NCT07254910 | Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma | NA RECRUITING |
| NCT07262619 | EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07271355 | Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial | PHASE3 RECRUITING |
| NCT07276529 | Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses | NA RECRUITING |
| NCT07277270 | A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07277322 | Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases | PHASE1|PHASE2 RECRUITING |
| NCT07281716 | Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC | PHASE1|PHASE2 RECRUITING |
| NCT07281768 | Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer | PHASE2 RECRUITING |
| NCT07283939 | Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays | NA RECRUITING |
| NCT07284849 | A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer | PHASE3 RECRUITING |
| NCT07285044 | The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas | PHASE2 RECRUITING |
| NCT07290309 | Survivors Uniting for Remote Guided Exercise | NA RECRUITING |
| NCT07291180 | A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis | NA RECRUITING |
| NCT07291414 | A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients | NA RECRUITING |
| NCT07292298 | Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates | PHASE2 RECRUITING |
| NCT07296887 | CARE Tool Study Aim 3 | NA RECRUITING |
| NCT07300150 | A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07304063 | Overcoming Barriers to Uptake of Cascade Screening | NA NOT_YET_RECRUITING |
| NCT07307664 | Increasing Germline Genetic Testing for Patients With Cancer | NA RECRUITING |
| NCT07317505 | A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07318389 | ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer | EARLY_PHASE1 RECRUITING |
| NCT07318805 | A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT07321106 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer | PHASE1 RECRUITING |
| NCT07337525 | A First in Human Study of PLT012 in Participants With Solid Tumor Cancers | PHASE1 RECRUITING |
| NCT07337590 | Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar | NA RECRUITING |
| NCT07345676 | Colorectal Cancer Screening Outreach | NA RECRUITING |
| NCT07349537 | Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors | PHASE1 RECRUITING |
| NCT07351071 | Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections | NA RECRUITING |
| NCT07361107 | Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC) | PHASE1 RECRUITING |
| NCT07361614 | Pilot Testing of a Colorectal Cancer Education Program | NA RECRUITING |
| NCT07363408 | Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer | PHASE1 NOT_YET_RECRUITING |
| NCT07381985 | Strategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment | NA ENROLLING_BY_INVITATION |
| NCT07391956 | Tier Palliative Care For Patients With Advanced Heart Failure or Cancer | NA RECRUITING |
| NCT07393906 | Colorectal Cancer Prevention Research Study: Eat Right, Screen Right | NA RECRUITING |
| NCT07397338 | Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07398456 | Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas | NA NOT_YET_RECRUITING |
| NCT07403981 | Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients | NA RECRUITING |
| NCT07405476 | Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment | PHASE2 RECRUITING |
| NCT07406087 | Navigation Intervention for Adolescent and Young Adult Cancer Survivors | NA RECRUITING |
| NCT07407647 | Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer | PHASE2 RECRUITING |
| NCT07408258 | Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07411599 | Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") | PHASE1|PHASE2 RECRUITING |
| NCT07415031 | A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies | PHASE2 RECRUITING |
| NCT07416552 | A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC) | PHASE1 RECRUITING |
| NCT07417488 | GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas | PHASE1 RECRUITING |
| NCT07419490 | Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy | NA RECRUITING |
| NCT07425054 | ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer | PHASE2 RECRUITING |
| NCT07429110 | ColoSeal™ ICD System Anastomotic Protection Pivotal Study | NA ACTIVE_NOT_RECRUITING |
| NCT07432633 | [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications | PHASE1|PHASE2 RECRUITING |
| NCT07433673 | Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC) | PHASE2 RECRUITING |
| NCT07436078 | Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors | NA RECRUITING |
| NCT07436637 | Guardant Shield Colorectal Cancer Screening | NA RECRUITING |
| NCT07436728 | A Study of TAK-505 in Adults With Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07446322 | FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer | PHASE2 RECRUITING |
| NCT07447050 | Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial | PHASE2 RECRUITING |
| NCT07454642 | AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors | PHASE1 RECRUITING |
| NCT07458347 | A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation | PHASE1 RECRUITING |
| NCT07463599 | Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma | PHASE1|PHASE2 RECRUITING |
| NCT07464236 | Improving Clinic Delivery of HIV-related Anal Health Services | NA NOT_YET_RECRUITING |
| NCT07487168 | Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors | PHASE1 RECRUITING |
| NCT07488676 | A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07500298 | Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer | PHASE1 RECRUITING |
| NCT07503808 | A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types | PHASE1 RECRUITING |
| NCT07511023 | Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum | PHASE2 NOT_YET_RECRUITING |
| NCT07522177 | Animated Storytelling to Promote Colorectal Cancer Screening | NA NOT_YET_RECRUITING |
| NCT07525206 | A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer | PHASE3 RECRUITING |
| NCT07527858 | Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer | PHASE2 RECRUITING |
| NCT07528963 | KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice | NA ENROLLING_BY_INVITATION |
| NCT07529808 | Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma | PHASE1|PHASE2 RECRUITING |
| NCT07535112 | A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation | PHASE1 RECRUITING |
| NCT07540572 | A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07542405 | A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families | NA NOT_YET_RECRUITING |
| NCT07544589 | A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers | PHASE1 RECRUITING |
| NCT07549412 | A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) | PHASE3 RECRUITING |
| NCT07550088 | BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases | PHASE2 RECRUITING |
| NCT07551596 | Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial | PHASE2 RECRUITING |
| NCT07553572 | Remote Monitoring and Symptom Management Digital Application | NA RECRUITING |
| NCT07555210 | Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy | NA RECRUITING |
| NCT07567027 | Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR) | NA RECRUITING |
| NCT07569250 | Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization | NA NOT_YET_RECRUITING |
| NCT07578571 | A Phase 1 Study of IM-1617 in Participants With Advanced Cancer | PHASE1 RECRUITING |
| NCT07580339 | Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer | PHASE2 NOT_YET_RECRUITING |
| NCT07582003 | S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas | PHASE1 NOT_YET_RECRUITING |
| NCT07592793 | Community Gateway to Health Study | NA ENROLLING_BY_INVITATION |
| NCT07594067 | TCR1188-ABC Cells in KRAS-mutated Cancers | PHASE1 RECRUITING |
| NCT07594626 | BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion | PHASE1|PHASE2 RECRUITING |
| NCT07595874 | Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 | PHASE2 RECRUITING |
| NCT07612007 | HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization | PHASE2 NOT_YET_RECRUITING |
| NCT07618273 | Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial | NA RECRUITING |
| NCT07620574 | Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study | PHASE3 ENROLLING_BY_INVITATION |
| NCT07627191 | GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer | EARLY_PHASE1 RECRUITING |
| NCT07629960 | A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations | PHASE1|PHASE2 RECRUITING |
| NCT07636785 | A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07638410 | Prehabilitation in High-risk Oncologic Surgery | NA RECRUITING |
| NCT07650357 | A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) | PHASE1 NOT_YET_RECRUITING |
| NCT07658196 | TLR9 Immunotherapy for Peritoneal Carcinomatosis | PHASE1 RECRUITING |
| NCT07659795 | A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer | PHASE2 RECRUITING |
| NCT07662031 | Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer | PHASE2 NOT_YET_RECRUITING |
| NCT07691489 | A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer | PHASE2 NOT_YET_RECRUITING |
| NCT07693751 | A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer | PHASE1|PHASE2 RECRUITING |
| NCT07701707 | Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors | NA NOT_YET_RECRUITING |
| NCT07702032 | Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) | PHASE3 RECRUITING |
| NCT07705334 | A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors | PHASE1 RECRUITING |
| NCT07715903 | Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy | PHASE1 NOT_YET_RECRUITING |
| NCT07735624 | RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer | PHASE2 RECRUITING |
| NCT07738939 | IKS04 Regimen in Advanced Solid Tumors That Express CA242 | PHASE1 NOT_YET_RECRUITING |
| NCT07743723 | A Study of IOV-5001 in Adults With Advanced Solid Tumors | PHASE1|PHASE2 NOT_YET_RECRUITING |
| NCT07748377 | Increasing Breast and Colorectal Cancer Screening in the Community | NA NOT_YET_RECRUITING |
| NCT07749586 | A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors | PHASE1|PHASE2 RECRUITING |
| NCT07750158 | Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease | PHASE3 RECRUITING |
| NCT07759921 | Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer | NA RECRUITING |
| NCT07781774 | Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach | NA NOT_YET_RECRUITING |
| NCT07781852 | Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer | EARLY_PHASE1 NOT_YET_RECRUITING |
| NCT07790718 | Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer | NA RECRUITING |
| NCT07795749 | Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) | PHASE2 RECRUITING |
| NCT07795801 | Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors | NA NOT_YET_RECRUITING |
| NCT07796334 | Colon Health Champion Program | NA NOT_YET_RECRUITING |
| NCT07796763 | A Global Trial of Trastuzumab Rezetecan (SHR-A1811) in Combination With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Colorectal Cancer Expressing HER2 | PHASE2 NOT_YET_RECRUITING |
| NCT07807345 | Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic | PHASE1 NOT_YET_RECRUITING |
| NCT07808151 | Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer | PHASE2 RECRUITING |
| NCT07811193 | A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum | PHASE2 RECRUITING |
| NCT07812805 | SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors | PHASE1 RECRUITING |
| NCT07842965 | CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial | PHASE1 NOT_YET_RECRUITING |